Gufic Biosciences Limited
Gufic Biosciences Limited (GUFICBIO.NS) Stock Overview
Explore Gufic Biosciences Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
28B
P/E Ratio
55.98
EPS (TTM)
$5.68
ROE
0.08%
GUFICBIO.NS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Gufic Biosciences Limited (GUFICBIO.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 30.51, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $459.62.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 55.98 and a market capitalization of 28B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.